Synergy Research Group Expands Operations to U.S.

Tuesday, September 22, 2009 08:05 AM

Russian CRO Synergy Research Group (SynRG) relocated its business development operations to a new office in the United States in an effort to attract U.S. drug development sponsors.  

The new office, based in North Kingstown, R.I., will be managed by SynRG’s new director of business development, Anna Ravdel.  Prior to joining the company, Ravdel was director of business development at Evidence Clinical and Pharmaceutical Research and at Worldwide Clinical Trials.

“We have always emphasized that one of the strategic goals set by SynRG is [to enhance the] research and investment attractiveness of Russia for foreign sponsors, so business development in the U.S.A. is a natural step along this strategic line," said SynRG CEO Igor Stefanov.

Headquartered in Moscow, SynRG has offices in Russia and Kazakhstan and plans to open a Ukrainian office as well as a virtual office in Prague before the end of the year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs